BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

NCT06120283 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

399

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Advanced Breast Cancer
Metastatic Breast Cancer
Hormone-receptor-positive Breast Cancer
Hormone Receptor Positive Breast Carcinoma
Hormone Receptor Positive Malignant Neoplasm of Breast
HER2-negative Breast Cancer
Hormone Receptor Positive HER-2 Negative Breast Cancer
Non-small Cell Lung Cancer

Interventions

DRUG: BGB-43395
DRUG: Fulvestrant
DRUG: Letrozole
DRUG: Elacestrant
DRUG: Anti-Diarrheal Agent

Sponsor

BeOne Medicines